期刊文献+

清胰汤对急性胰腺炎患者血管活性物质含量的影响 被引量:1

The effect of Qingyi decoction on Vaso-active substance in acute pancreatitis patieuts
下载PDF
导出
摘要 目的:从胰腺血液循环障碍的角度探讨清胰汤治疗急性胰腺炎(AP)的机制。方法:将56例AP患者分为观察组(30例)及对照组(26例),前者给予西药联合清胰汤治疗,后者单纯给予西药治疗,比较血管活性物质一氧化氮(NO)及血栓素B2(TXB2)的含量,同时比较白细胞计数(WBC)、血清胰淀粉酶(AL)、C反应蛋白(CRP)的含量。结果:治疗前两组患者的NO显著降低,治疗后呈不同程度回升,且观察组高于对照组(P<0.05);治疗前两组TXB2、WBC、AL及CRP显著升高,治疗后有所下降,且观察组低于对照组(P<0.05)。结论:清胰汤可能是通过增加NO含量、降低TXB2含量,以缓解血管阻力,改善胰腺血液循环,减轻胰腺组织坏死,从而发挥治疗AP的作用。 Objective: To observe the mechanism of Qingyi decoction to treat acute pancreatitis (AP). Methods: 56 AP pa tients were divided into two groups: observation group(30 cases) and control group(26 cases). Basing on the treatment of western medicine, the observation group was given Qingyi decoction, twice a day, but the control ones were not. The vasoactive substance including nitric oxide (NO) and thromboxane B2(TXB2) were detected, so were the leucocytes(WBC), serum amylase(AL)and C reaction protein (CRP). Results: The quantity of NO was low before treatment, but it increased after being treated, especially NO in the observation group was significantly higher than that of control group(P0.05). The TXB2, WBC, AL and CRP were high before treatment, but it decreased after being treated, and the upper 4 indexes in observation group was significantly lower than that of control group (P0.05). Conclusion: Qingyi decoction could increase quantities of NO and decrease TXB2, suggesting it could relieve the obstruction of in the vessels and improve blood circulation and alleviated putrescence of the pancreas, which might be a potential mechanism of Qingyi decoction to treat acute pancreatitis.
作者 李伟强
出处 《中国当代医药》 2010年第3期80-81,共2页 China Modern Medicine
关键词 清胰汤 急性胰腺炎 一氧化氮 血栓素B2 血管活性物质 Qingyi decoction Acute pancreatitis Nitric oxide Thromboxane B2 Vaso-active substance
  • 相关文献

参考文献5

二级参考文献37

  • 1王婧,阴赪宏,张淑文,王宝恩.大黄类药物治疗重症急性胰腺炎的进展[J].中国中西医结合急救杂志,2005,12(5):318-320. 被引量:63
  • 2顾超,邹晓平.ERCP术后胰腺炎的药物预防进展[J].中华消化内镜杂志,2006,23(6):476-478. 被引量:12
  • 3Rao SS. A serial histologic study of the development and progression of aute pancreatitis in the rat. Am J Pathol, 1981,103:39- 42.
  • 4Karne S, Gorelick FS. Etiopthogenesis of acute pancreatitis. Surg Clin North Am, 1999,79:699.
  • 5Iida T, Yokoi H, Kawarada Y. The effects of a thromboxane A2synthesis inhibitor and a prostaglandin I2 analogue on experimental acute necrotizing pancreatitis in rats. Pancreas, 1998,17:140-147.
  • 6Lake-bakaar G, Lyubsky S. Dose-dependent effect of continuous subcutaneous verapamil infusion on experimental acute pancreatitis in mice. Dig Dis Sci, 1995,40:2349-2354.
  • 7Zhou W, Shen F, Han Q, et al. Evidence for altered cellular calcium in the pathogenetic mechanism of acute pancreatitis in rats. J Surg Res, 1996,60:147-155.
  • 8Liaudet L, Soriano FG, Szabo C. Biology of nitric oxide signaling.Crit Care Med, 2000,28: N37-52.
  • 9Denham W, Yang J, Wang H, et al. Inhibition of p38 mitogen activate kinase attenuates the severity of pancreatitis-induced adult respiratory distress syndrome. Crit Care Med, 2000,28:2567-2572.
  • 10Yucel K. Alhan E. Kucuktulu U. et al. The effects of prostaglandin E1 on the microperfusion of the pancreas during acute necrotizing pancreatitis in rats. Hepatogastroenterology.2002. 49: 544-518.

共引文献14

同被引文献22

引证文献1

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部